Clinicopathologic Features of Breast Carcinomas Classified by Biomarkers and Correlation with Microvessel Density and VEGF Expression: A Study from Thailand |
Chuangsuwanich, Tuenjai
(Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University)
Pongpruttipan, Tawatchai (Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University) O-charoenrat, Pornchai (Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University) Komoltri, Chulaluk (Epidemiology Unit, Faculty of Medicine Siriraj Hospital, Mahidol University) Watcharahirun, Suwapee (Department of Pathology, Surin Hospital, Mueng District) Sa-nguanraksa, Doonyapat (Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University) |
1 | Kim MJ, Ro JY, Ahn S H, et al (2006). Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. Hum Pathol, 37, 1217-26. DOI ScienceOn |
2 | Liu Y, Tamimi RM, Collins LC, et al (2011). The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study. Breast Cancer Res Treat, 129, 175-84. DOI ScienceOn |
3 | Livasy CA, Karaca G, Nanda R, et al (2006). Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol, 19, 264-71. DOI ScienceOn |
4 | Carey LA, Perou CM, Livasy CA, et al (2006). Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, 295, 2492-502. DOI ScienceOn |
5 | Chaiwun B, Nakrungsee S, Sukhamwang N, Srisukho S (2010). A study of high-nuclear-grade breast cancer in Thailand: subclassification and correlation with prognostic factors and immunohistochemical study. Breast Cancer, 17, 35-41. DOI |
6 | Chuthapisith S, Permsapaya W, Warnnissorn M, et al (2012). Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women. Asian Pac J Cancer Prev, 13, 459-62. 과학기술학회마을 DOI ScienceOn |
7 | Taliano RJ, Lu S, Singh K et al (2013). Calretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis. Hum Pathol, 44, 2743-50. DOI ScienceOn |
8 | Tan GH, Taib NA, Choo WY, Teo SH, Yip CH (2009). Clinical characteristics of triple-negative breast cancer: experience in an Asian developing country. Asian Pac J Cancer Prev, 10, 395-8. |
9 | Thike AA, Cheok PY, Jara-Lazaro AR, et al (2010). Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol, 23, 123-33. DOI ScienceOn |
10 | Yang W, Klos K, Yang Y, et al (2002). ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma. Cancer, 94, 2855-61. DOI ScienceOn |
11 | Perou CM, Sorlie T, Eisen MB, et al (2000). Molecular portraits of human breast tumours. Nature, 406, 747-52. DOI ScienceOn |
12 | Reis-Filho JS, Tutt AN (2008). Triple negative tumours: a critical review. Histopathology, 52, 108-18. |
13 | Lopes N, Sousa B, Vieira D, Milanezi F, Schmitt F (2009). Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles. Histopathology, 55, 594-9. DOI ScienceOn |
14 | Nielsen TO, Hsu FD, Jensen K, et al (2004). Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res, 10, 5367-74. DOI ScienceOn |
15 | Ribeiro-Silva A, Ribeiro do Vale F, Zucoloto S (2006). Vascular endothelial growth factor expression in the basal subtype of breast carcinoma. Am J Clin Pathol, 125, 512-8. DOI |
16 | Han W, Nicolau M, Noh DY, Jeffrey SS (2010). Characterization of molecular subtypes of Korean breast cancer: an ethnically and clinically distinct population. Int J Oncol, 37, 51-9. |
17 | Sorlie T, Perou CM, Tibshirani R, et al (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA, 98, 10869-74. DOI ScienceOn |
18 | Sotiriou C, Neo SY, McShane LM, et al (2003). Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA, 100, 10393-8. DOI ScienceOn |
19 | Spitale A, Mazzola P, Soldini D, Mazzucchelli L, Bordoni A (2009). Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Ann Oncol, 20, 628-35. DOI ScienceOn |
20 | Dent R, Trudeau M, Pritchard KI, et al (2007). Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res, 13, 4429-34. DOI ScienceOn |
21 | Goldhirsch A, Wood WC, Coates AS, et al (2011). Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol, 22, 1736-47. DOI ScienceOn |
22 | Irvin WJ Jr, Carey LA (2008). What is triple-negative breast cancer? Eur J Cancer, 44, 2799-805. DOI ScienceOn |
23 | Jumppanen M, Gruvberger-Saal S, Kauraniemi P, et al (2007). Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers. Breast Cancer Res, 9, 16. |
24 | Foulkes WD, Stefansson IM, Chappuis PO, et al (2003). Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst, 95, 1482-5. DOI ScienceOn |
25 | Sa-Nguanraksa D, Chuangsuwanich T, Pongpruttipan T, et al (2013). Vascular endothelial growth factor 634G/C polymorphism is associated with increased breast cancer risk and aggressiveness. Mol Med Rep, 8, 1242-50. |
![]() |